OnCore Login

Return to Trial Database

HCRN-MEL91-1

A Phase III Study Comparing Cisplatin, Dacarbazine, Carmustine and Tamoxifen vs Dacarbazine Alone in Patients with Advanced Melanoma

Status

Study Completed

Cancer Type(s)

Melanoma

Study Contact

Publications

A Phase III Multicenter Randomized Trial of DTIC, Cisplatin, BCNU and Tamoxifen Versus DTIC Alone in Patients with Metastatic Melanoma
  • SB Saxman, ML Meyers, PB Chapman, AN Destro, KS Panageas, CB Begg, F Monaco, SS Agarwala, LM Schuchter, MS Ernstoff, LH Einhorn, JM Kirkwood, AN Houghton
A Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine Alone in Patients with Metastatic Melanoma
  • PB Chapman, LH Einhorn, ML Meyers, SB Saxman, AN Destro, KS Panageas, CB Begg, SS Agarwala, LM Schuchter, MS Ernstoff, AN Houghton , JM Kirkwood

Trial Locations

All sites in which the trial HCRN-MEL91-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278